Media - Truvian

January 23, 2025

Theranos Broke Rules That This Blood Test Company Vows to Live By

August 31, 2023

Truvian Progresses on Blood Testing Benchtop

July 27, 2023

Truvian’s blood testing platform provides lab quality results

October 22, 2021

Thera-who? These Biotech Firms are Looking to Push What’s Possible with Blood

September 4, 2021

Silicon Valley Still Believes in Promise of Easy Blood Tests Despite Theranos Scandal

August 30, 2021

Truvian CEO: Theranos’ One Drop Blood Testing ‘Was Always Science Fiction’

August 28, 2021

Theranos Didn’t Stop the Search for the Next Healthcare Star

August 26, 2021

The Prospects, Prominence, Possibilities of Point-of-Care Testing

March 12, 2021

Beyond Bad Blood: Healthtech Startup Truvian Hopes to Succeed Where Theranos Failed

March 2, 2021

Truvian Sciences Receives $105 Million Series C Funding

February 24, 2021

Truvian Sciences Raises $105M Series C to Fund Development of Point-of-Care Testing Platform

February 24, 2021

No More Waiting for Central Lab Results: Truvian Raises $105M

February 24, 2021

Truvian Raises $105M, Plans to Submit Benchtop Blood-Testing Tech to FDA

February 24, 2021

Truvian Sciences Raises More Than $105M in Series C Financing

February 24, 2021

Truvian Closes $105M Series C Financing Round

February 24, 2021

San Diego’s Truvian Sciences Raises $105M to Bring Common Wellness Blood Tests Closer to Home

February 24, 2021

Truvian Sciences Snares $105M for its Many-in-One Blood Testing Machine

February 24, 2021

Truvian Closes $105M Oversubscribed Series C

February 19, 2021

Empowering Consumers with Point-of-Care Blood Testing

February 3, 2021

Women Make Notable Gains in Local STEM Workforce

January 20, 2021

New Technology, Vaccine Availability Reshaping Hospital Care

January 11, 2021

COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care

December 21, 2020

AACC 2020: COVID-19 Paved Way For ‘Retailization,’ Innovation In Point-Of-Care Testing, Now What?

September 14, 2020

San Diego’s White-Collar Workers Are Still in Limbo, but Some Eyeing a Return to the Office

September 14, 2020

OC Startups Now

September 2, 2020

Forbes Feature: The Pandemic Can Drive Healthcare Reform

August 4, 2020

Founders’ Story: Truvian Sciences

March 25, 2020

Truvian Sciences’ Point-of-Care Diagnostics Could Provide Long-Term Solution for Future Pandemics

January 27, 2020

True Blood? In the Shadow of Theranos, Truvian Revives Dream of Low-Cost Blood Tests

December 30, 2019

ABC 10 News San Diego – KGTV Feature

December 23, 2019

Company Developing 5-Drop, 20-Minute Blood Test

December 20, 2019

Blood Testing Nears a Turning Point as the Evidence Becomes Undeniable

December 10, 2019

Truvian Sciences Moves Closer to Commercialization of Benchtop Blood Testing System

December 3, 2019

Truvian Seeks to Decentralize Blood Testing

November 27, 2019

Health Tech Funding Snapshot—Sony Joins $42M Round in Endoscopy AI Company; Wellframe Raises $20M

November 26, 2019

Health and Life Science Deals

November 24, 2019

Funding Goes to Cancer Drug Developers, Company Billed as the Anti-Theranos

November 22, 2019

Truvian Sciences Raises $27m As It Tries To Succeed Where Theranos Failed

November 21, 2019

Truvian Sciences Looks to Disrupt Dx Market With Three-Modality Platform

November 21, 2019

Theranos-like Blood-testing Startup Raises $27m

November 20, 2019

Blood Test Startup Truvian Sciences Closes $27M Series B Financing Round

November 20, 2019

Truvian Nets $27m To Build Its Comprehensive Benchtop Blood Testing Machine

November 20, 2019

Truvian Sciences Raises $27.1m For A Testing System Needing Only “A Small Sample Of Blood”

November 20, 2019

With Echoes Of Theranos, Truvian Sciences Revives The Dream Of Low-cost, Accessible Blood Tests

November 20, 2019

Blood-Testing Startup Truvian Raises Fresh Capital

November 20, 2019